These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6661441)

  • 1. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine beta-hydroxylase by anti-thyroid agents, methimazole and propylthiouracil.
    Hidaka H; Nagasaka A
    Biochem Pharmacol; 1977 Jun; 26(11):1092-3. PubMed ID: 880264
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of dopamine beta-hydroxylase by thiazoline-2-carboxylate, a suspected physiological product of D-amino acid oxidase.
    Naber N; Venkatesan PP; Hamilton GA
    Biochem Biophys Res Commun; 1982 Jul; 107(1):374-80. PubMed ID: 6127076
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of dopamine-beta-hydroxylase, A copper enzyme, by bleomycin.
    Matsui H; Kato T; Yamamoto C; Takita T; Takeuchi T; Umezawa H; Nagatsu T
    J Antibiot (Tokyo); 1980 Apr; 33(4):435-40. PubMed ID: 6157665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine-beta-hydroxylase by alternative electron donors.
    Rosenberg RC; Gimble JM; Lovenberg W
    Biochim Biophys Acta; 1980; 613(1):62-72. PubMed ID: 7378421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dopamine beta-hydroxylase by some new thiourea derivatives.
    Oyama H; Izumi H; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(3):277-80. PubMed ID: 1267825
    [No Abstract]   [Full Text] [Related]  

  • 10. Ascorbate 2-sulfate inhibits dopamine beta-hydroxylase reaction, but not ascorbate oxidase reaction.
    Hatanaka H; Egami F; Kato T; Nagatsu T
    J Biochem; 1975 Oct; 78(4):821-4. PubMed ID: 1240099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochem Pharmacol; 1973 Oct; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct spectrophotometric detection of ascorbate free radical formed by dopamine beta-monooxygenase and by ascorbate oxidase.
    Skotland T; Ljones T
    Biochim Biophys Acta; 1980 Jun; 630(1):30-5. PubMed ID: 7388045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of biochemical parameters and kinetic properties of dopamine-beta-hydroxylase activity from cat and rat adrenals.
    Fortin D; Coulon JF; Roberge AG
    Comp Biochem Physiol B; 1993 Mar; 104(3):567-75. PubMed ID: 8482079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible inhibition of dopamine-beta-hydroxylase by cysteine.
    Izumi H; Oyama H; Hayakari M; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(4):488-9. PubMed ID: 938576
    [No Abstract]   [Full Text] [Related]  

  • 16. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine beta-monooxygenase by histidine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1831-3. PubMed ID: 1205455
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of dopamine-beta-hydroxylase by a metabolite of pyrazole, 4-hydroxypyrazole, in vitro.
    Pispa JP; MacDonald E
    FEBS Lett; 1980 Oct; 120(1):64-6. PubMed ID: 7439391
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibitory effect of serum from diethyldithiocarbamate treated rats on bovine adrenal dopamine-beta-hydroxylase activity.
    Jarvis JA; Magos L; Jacobs R
    J Appl Toxicol; 1981 Feb; 1(1):26-9. PubMed ID: 6309944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine beta-hydroxylase by captopril.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Pharmacol; 1989 Mar; 38(6):1011-3. PubMed ID: 2539161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.